- Report
- November 2024
- 286 Pages
Global
From €5385EUR$5,450USD£4,482GBP
- Report
- November 2024
- 296 Pages
Global
From €5385EUR$5,450USD£4,482GBP
- Report
- November 2024
- 287 Pages
Global
From €5385EUR$5,450USD£4,482GBP
- Report
- November 2024
- 389 Pages
Global
From €5385EUR$5,450USD£4,482GBP
- Report
- November 2024
- 387 Pages
Global
From €5385EUR$5,450USD£4,482GBP
- Report
- November 2024
- 177 Pages
Global
From €5533EUR$5,600USD£4,605GBP
- Report
- November 2024
- 183 Pages
Global
From €5533EUR$5,600USD£4,605GBP
- Report
- November 2024
- 289 Pages
Global
From €5533EUR$5,600USD£4,605GBP
- Report
- November 2024
- 250 Pages
Global
From €5385EUR$5,450USD£4,482GBP
- Report
- November 2024
- 179 Pages
Global
From €4891EUR$4,950USD£4,071GBP
- Report
- November 2024
- 184 Pages
Global
From €4891EUR$4,950USD£4,071GBP
- Report
- November 2024
- 192 Pages
Global
From €4891EUR$4,950USD£4,071GBP
- Report
- November 2024
- 183 Pages
Global
From €4891EUR$4,950USD£4,071GBP
- Report
- November 2024
- 196 Pages
Global
From €4891EUR$4,950USD£4,071GBP
- Report
- November 2024
- 94 Pages
Global
From €5533EUR$5,600USD£4,605GBP
- Report
- November 2024
- 197 Pages
Global
From €4891EUR$4,950USD£4,071GBP
- Report
- November 2024
- 188 Pages
Global
From €5385EUR$5,450USD£4,482GBP
- Report
- November 2024
- 326 Pages
Global
From €5385EUR$5,450USD£4,482GBP
- Report
- November 2024
- 182 Pages
Global
From €5385EUR$5,450USD£4,482GBP
- Report
- November 2024
- 196 Pages
Global
From €5533EUR$5,600USD£4,605GBP
The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more